Waldemar Priebe serves as Executive at Moleculin Biotech, Inc., where they oversee executive responsibilities. Since joining the company, Waldemar Priebe has executed 19 insider transactions totaling $303.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 28, 2023 involved selling 10,000 shares valued at $10.4K.
Waldemar Priebe currently holds 156,807 shares of Moleculin Biotech, Inc. (MBRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Waldemar Priebe has been a net seller of MBRX stock. They have purchased $0 and sold $303.1K worth of shares.
Waldemar Priebe's most recent insider trade was on Mar 28, 2023, when they sold 10,000 shares at $1.04 per share.
Get notified when new Form 4 filings are submitted
| $1.09 |
| Planned |
| Mar 24, 2023 | CNSP | $5.4K | Sale | 5,000 | $1.08 | Planned |
| Mar 23, 2023 | CNSP | $10.8K | Sale | 10,000 | $1.08 | Planned |
| Mar 22, 2023 | CNSP | $5.4K | Sale | 5,000 | $1.08 | Planned |
| Mar 21, 2023 | CNSP | $5.5K | Sale | 5,000 | $1.10 | Planned |
| Mar 20, 2023 | CNSP | $5.4K | Sale | 5,000 | $1.08 | Planned |
| Mar 17, 2023 | CNSP | $5.7K | Sale | 5,000 | $1.13 | Planned |
| Mar 16, 2023 | CNSP | $6.2K | Sale | 5,000 | $1.24 | Planned |
| Mar 15, 2023 | CNSP | $6.1K | Sale | 5,000 | $1.22 | Planned |
| Mar 14, 2023 | CNSP | $6.8K | Sale | 5,000 | $1.35 | Planned |
| Mar 13, 2023 | CNSP | $6.5K | Sale | 5,000 | $1.30 | Planned |
| Mar 10, 2023 | CNSP | $6.5K | Sale | 5,000 | $1.29 | Planned |
| Dec 9, 2022 | CNSP | $6.8K | Sale | 2,798 | $2.43 | Planned |
| Dec 8, 2022 | CNSP | $13.2K | Sale | 5,500 | $2.40 | Planned |
| Dec 7, 2022 | CNSP | $13.5K | Sale | 5,500 | $2.46 | Planned |
| Dec 6, 2022 | CNSP | $13.6K | Sale | 5,500 | $2.47 | Planned |
| May 5, 2020 | CNSP | $0 | Other | 1,495,867 | $N/A | Discretionary |
| Aug 16, 2017 | MBRX | $170.0K | Sale | 100,000 | $1.70 | Discretionary |